Nasdaq CopenhagenIFRS · DKK

WILLIAM DEMANT INVEST A/S

WILLIAM DEMANT INVEST A/S is a Danish investment holding company centered on the ownership of business interests in hearing healthcare. Its portfolio structure is built around the William Demant group, which develops and commercializes hearing aids, diagnostic equipment, and related audiology solutions through operating subsidiaries.

Kysy yhtiöstä
Liikevaihto30,1mrd DKK
+2,6 %v/v
Liikevoitto (EBIT)4 425milj. DKK
−22,6 %v/v
EBIT-marginaali14,7%
−4,8 %-yks.v/v
Nettotulos1 117milj. DKK
−53,7 %v/v
Vapaa kassavirta4 134milj. DKK
+0,3 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

010203040mrd DKK2020: 19,3 mrd DKK2020: EBIT 2,0 mrd DKK20202021: 23,6 mrd DKK2021: EBIT 4,8 mrd DKK20212022: 25,5 mrd DKK2022: EBIT 5,3 mrd DKK20222023: 28,7 mrd DKK2023: EBIT 4,0 mrd DKK20232024: 29,3 mrd DKK2024: EBIT 5,7 mrd DKK20242025: 30,1 mrd DKK2025: EBIT 4,4 mrd DKK202530,14,4
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: WILLIAM DEMANT INVEST A/S

Liiketoiminta

Osuus liikevaihdosta
Hearing aids55 %

Devices and accessories for treating hearing loss and improving hearing performance.

Diagnostic equipment20 %

Audiology testing and fitting systems used by hearing care professionals.

Hearing care solutions15 %

Software, fitting tools, and services used in hearing rehabilitation and sales.

Investment holdings10 %

Ownership of operating businesses and portfolio interests within hearing healthcare.

Asiakkaat

The company serves hearing care professionals, audiologists, clinics, and distributors that specify and sell hearing solutions to end users. Its operating businesses also reach consumers and patients who need hearing devices, fittings, and follow-up support through professional channels. Because the group combines devices, diagnostics, and fitting support, its customer base is tied to the broader hearing healthcare value chain.

Hearing care professionals

They buy hearing aids, fitting software, and accessories to fit and support patients.

Audiology clinics and hospitals

They buy diagnostic equipment and workflows for hearing tests and clinical assessment.

Distributors and retail channels

They buy finished hearing products for resale through hearing care networks.

End users/patients

They receive the devices and services through professional fitting channels.

Strategia

The company’s strategic position rests on owning and supporting a portfolio of hearing healthcare businesses with global reach and technical depth. Its long-term priorities are typically centered on maintaining product relevance, strengthening hearing care channels, and supporting innovation across devices and diagnostics.

Portfolio stewardshipPitkä aikaväli

The company is structured around ownership of operating assets, so capital allocation and portfolio focus drive value creation.

Product and technology developmentKeskipitkä aikaväli

Hearing solutions compete on sound quality, fit, and clinical performance.

Channel strengthKeskipitkä aikaväli

Access to audiologists, clinics, and distributors determines market reach and adoption.

Maantiede

The group is based in Denmark and operates through an international hearing healthcare platform. Its business is inherently global because hearing aids, diagnostics, and hearing care products are sold through local clinics and distribution networks across many countries. Geography matters because reimbursement systems, channel structure, and local hearing care access influence how products are sold and supported.

Riskit

The main risks are tied to reliance on the hearing healthcare market, where demand depends on demographics, reimbursement, and professional channel adoption. As an investment holding structure, the company is also exposed to concentration in a relatively specialized industry and to valuation changes in its underlying businesses.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Concentration in hearing healthcare1Channel dependence2Competitive pressure3Regulatory and reimbursement changes4
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Concentration in hearing healthcareVaikutus: KorkeaTodennäköisyys: Korkea

    The group’s value depends heavily on a specialized sector rather than a broad product base.

    Kohdistuu: Ownership of hearing-related operating businesses

  2. Channel dependenceVaikutus: KorkeaTodennäköisyys: Korkea

    Products are sold through audiologists, clinics, and distributors, so access to those channels affects growth.

    Kohdistuu: Professional hearing care networks

  3. Competitive pressureVaikutus: KeskitasoTodennäköisyys: Korkea

    Hearing devices and diagnostics require continuous innovation and brand trust.

    Kohdistuu: Hearing aids and audiology equipment

  4. Regulatory and reimbursement changesVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Healthcare purchasing and adoption can shift with national rules and coverage decisions.

    Kohdistuu: Country-specific hearing care markets

Kysy Clarifolta: WILLIAM DEMANT INVEST A/S

Kirjanpito

Harkinnanvaraiset erät
Investment valuation

Holding-company accounts can be sensitive to how investments are measured and consolidated.

Vaikutus: Can materially change reported equity and earnings

Goodwill and intangibles

Acquisitions in hearing healthcare often create significant intangibles that require impairment testing.

Vaikutus: Could affect operating profit and equity

Revenue recognition

Device sales, accessories, and services may recognize revenue at different times.

Vaikutus: Affects timing of reported sales

Provisions

Warranty, returns, or product-quality claims may require estimates.

Vaikutus: Can affect expenses and liabilities

Päivitetty: 24.10.2026